Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...

McGill University researchers have demonstrated that AMPA receptors (AMPARs), which mediate fast excitatory neurotransmission ...

Protalix Biotherapeutics (PLX) has gained investor’s attention, and reported a record revenue increase in its fiscal year 2024, primarily due ...

Transfect the cells with the recombinant vector using Lipofectamine ... Use the cells on the coverslip to check the level of GFP fusion protein expression with high-resolution fluorescence ...

India’s Aditya-L1 captures an unprecedented solar flare, IISc researchers unlock gene activation with mini proteins in yeast, ...

Quercus Biosolutions is a startup using generative AI to create a new generation of crop protection products based on designer mini proteins.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The Central Board of Secondary Education (CBSE) is conducting the Class 12 board exams for the 2025 academic year. The ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic proteins. High titer capability is essential for delivering superior results and ...

This protein ... GMP Recombinant Human Fibronectin Fragment (Cat. No. GMP-FINH18) supports the maintenance of MSC stemness across multiple passages, ensuring high expression of MSC markers CD73 ...

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.